Cargando…
508. Nirmatrelvir/ritonavir use among patients with cancer and COVID-19 is associated with improved clinical outcomes: Single-institution case-control study
BACKGROUND: Patients with cancer are at increased risk for severe and lethal COVID-19, compared to the general population. Currently, with no anti-spike monoclonal antibodies available against circulating variants of SARS-CoV-2, the logistic limitations of outpatient remdesivir infusions, and lack o...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678017/ http://dx.doi.org/10.1093/ofid/ofad500.577 |